HeiLongJiang ZBD Pharmaceutical Hits Day Low Amid Price Pressure at CNY 4.65

HeiLongJiang ZBD Pharmaceutical Co., Ltd. experienced significant volatility today, with the stock hitting an intraday low of CNY 4.65, reflecting a decline of 7.87% for the day. This performance is notably weaker compared to the China Shanghai Composite, which saw a modest decrease of 0.43%. Over the past week, HeiLongJiang ZBD has faced a steep decline of 21.34%, and its one-month performance shows a staggering drop of 35.8%. Year-to-date, the stock has lost 47.59%, and its one-year performance stands at a substantial decrease of 58.29%. The long-term outlook appears challenging, with a three-year decline of 70.23% and a five-year drop of 71.31%. Financial metrics indicate underlying issues, including a low Return on Capital Employed (ROCE) of 2.85% and a concerning Debt to Equity ratio. The company has reported negative results for the last three consecutive quarters, with net sales declining at an annual rate of 11.66%. These factors contribute to a complex market position for HeiLongJiang ZBD Pharmaceutical Co., Ltd. in the pharmaceuticals and biotechnology sector.